Zacks Research Comments on AMETEK's Q1 Earnings (NYSE:AME)

AMETEK logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Zacks Research trimmed its Q1 2027 EPS estimate for AMETEK to $2.22 from $2.23, while maintaining a Strong Buy rating. It also lowered full-year estimates for 2027 and 2028 to $9.52 and $10.35 per share, respectively.
  • AMETEK’s latest reported quarter beat expectations, with EPS of $2.21 versus the $2.11 consensus and revenue of $2.22 billion versus $2.12 billion expected. Revenue rose 17.3% year over year.
  • Analyst sentiment remains positive overall: MarketBeat reports a Moderate Buy consensus rating and an average price target of $278.88.
  • MarketBeat previews the top five stocks to own by December 1st.

AMETEK, Inc. (NYSE:AME - Free Report) - Research analysts at Zacks Research lowered their Q1 2027 earnings estimates for shares of AMETEK in a report released on Tuesday, November 17th. Zacks Research analyst Team now anticipates that the technology company will post earnings of $2.22 per share for the quarter, down from their prior estimate of $2.23. Zacks Research has a "Strong-Buy" rating on the stock. The consensus estimate for AMETEK's current full-year earnings is $8.57 per share. Zacks Research also issued estimates for AMETEK's Q3 2027 earnings at $2.45 EPS, Q4 2027 earnings at $2.53 EPS, FY2027 earnings at $9.52 EPS, Q1 2028 earnings at $2.57 EPS, Q2 2028 earnings at $2.59 EPS, Q3 2028 earnings at $2.58 EPS and FY2028 earnings at $10.35 EPS.

AMETEK (NYSE:AME - Get Free Report) last posted its earnings results on Tuesday, November 3rd. The technology company reported $2.21 EPS for the quarter, topping the consensus estimate of $2.11 by $0.10. The firm had revenue of $2.22 billion during the quarter, compared to analysts' expectations of $2.12 billion. AMETEK had a net margin of 19.91% and a return on equity of 17.12%. The company's quarterly revenue was up 17.3% compared to the same quarter last year. During the same period last year, the company posted $1.89 EPS.

Other analysts have also issued reports about the stock. BMO Capital Markets raised their price objective on shares of AMETEK from $262.00 to $282.00 in a report on Wednesday, August 5th. Robert W. Baird upped their target price on AMETEK from $275.00 to $280.00 and gave the stock a "neutral" rating in a report on Monday, October 5th. Truist Financial reissued a "buy" rating and issued a $329.00 target price (up from $316.00) on shares of AMETEK in a research report on Friday, November 13th. Royal Bank Of Canada raised their target price on AMETEK from $291.00 to $308.00 and gave the company an "outperform" rating in a research note on Wednesday, November 4th. Finally, BNP Paribas Exane raised their target price on AMETEK from $280.00 to $290.00 and gave the company an "outperform" rating in a research note on Friday, September 11th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and five have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, AMETEK presently has an average rating of "Moderate Buy" and a consensus price target of $278.88.

Check Out Our Latest Analysis on AME

AMETEK Price Performance

Shares of NYSE AME opened at $235.72 on Thursday. AMETEK has a 1 year low of $188.47 and a 1 year high of $261.16. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.43 and a quick ratio of 0.91. The company's 50-day moving average is $243.36 and its 200 day moving average is $235.26. The stock has a market capitalization of $54.06 billion, a P/E ratio of 33.25, a P/E/G ratio of 2.10 and a beta of 0.96.

AMETEK Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 18th. Investors of record on Friday, December 4th will be paid a $0.34 dividend. The ex-dividend date is Friday, December 4th. This represents a $1.36 annualized dividend and a dividend yield of 0.6%. AMETEK's dividend payout ratio is presently 19.18%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Fi3 FINANCIAL ADVISORS LLC raised its stake in AMETEK by 25.8% during the third quarter. Fi3 FINANCIAL ADVISORS LLC now owns 1,318 shares of the technology company's stock valued at $327,000 after buying an additional 270 shares during the last quarter. Innovator Capital Management LLC purchased a new stake in shares of AMETEK in the third quarter worth $3,156,000. Coastal Bridge Advisors LLC bought a new position in shares of AMETEK during the third quarter valued at $856,000. iSAM Funds UK Ltd bought a new position in shares of AMETEK during the third quarter valued at $297,000. Finally, Integrated Wealth Concepts LLC increased its holdings in shares of AMETEK by 48.6% during the third quarter. Integrated Wealth Concepts LLC now owns 12,104 shares of the technology company's stock valued at $2,999,000 after acquiring an additional 3,961 shares in the last quarter. Institutional investors own 87.43% of the company's stock.

AMETEK News Roundup

Investors following AME have been watching these news items:

  • Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $8.55 from $8.40 and its Q4 2026 estimate to $2.28 from $2.23; its Q2 2027 estimate also edged up to $2.33 from $2.32. AMETEK analyst estimate updates
  • Neutral Sentiment: Zacks retained its Strong Buy rating despite the changes to its forecasts. AMETEK analyst estimate updates
  • Negative Sentiment: Zacks cut estimates across several later periods, including FY2027 EPS to $9.52 from $9.58 and FY2028 to $10.35 from $10.66. It also lowered quarterly forecasts for 2027 and 2028, signaling a more cautious outlook for earnings growth and potentially pressuring the stock. AMETEK analyst estimate updates

AMETEK Company Profile

(Get Free Report)

AMETEK, Inc. is a global manufacturer of electronic instruments and electromechanical products. Its businesses serve a range of markets, including aerospace, energy, industrial manufacturing, medical, and transportation. The company's products include analytical and process instruments, monitoring and measurement systems, aerospace components, precision motors and pumps, and engineered materials. AMETEK organizes its operations into two groups: Electronic Instruments and Electromechanical. Founded in 1930, AMETEK serves customers around the world through manufacturing facilities, sales offices, and service operations in multiple countries.

Featured Stories

Earnings History and Estimates for AMETEK (NYSE:AME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in AMETEK Right Now?

Before you consider AMETEK, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.

While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines